Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors

Alex Abramson(Massachusetts Institute of Technology), Morten Revsgaard Frederiksen(Novo Nordisk (Denmark)), Andreas Vegge(Novo Nordisk (Denmark)), Brian Jensen(Novo Nordisk (Denmark)), Mette H. Poulsen(Novo Nordisk (Denmark)), Brian Mouridsen(Novo Nordisk (Denmark)), Mikkel Oliver Jespersen(Novo Nordisk (Denmark)), Rikke Kaae Kirk(Novo Nordisk (Denmark)), Jesper Windum(Novo Nordisk (Denmark)), František Hubálek(Novo Nordisk (Denmark)), Jorrit J. Water(Novo Nordisk (Denmark)), Johannes Josef Fels(Novo Nordisk (Denmark)), Stefán B. Gunnarsson(Novo Nordisk (Denmark)), Adam Bohr(Novo Nordisk (Denmark)), Ellen Marie Straarup(Novo Nordisk (Denmark)), Mikkel Wennemoes Hvitfeld Ley(Novo Nordisk (Denmark)), Xiaoya Lu(Johns Hopkins University), Jacob Wainer(Fractyl (United States)), Joy Collins(Massachusetts Institute of Technology), Siddartha Tamang(Massachusetts Institute of Technology), Keiko Ishida(Brigham and Women's Hospital), Alison Hayward(Brigham and Women's Hospital), Peter F. Herskind(Novo Nordisk (Denmark)), Stephen T. Buckley(Novo Nordisk (Denmark)), Niclas Roxhed(Massachusetts Institute of Technology), Róbert Langer(Massachusetts Institute of Technology), Ulrik L. Rahbek(Novo Nordisk (Denmark)), Giovanni Traverso(Brigham and Women's Hospital)
Nature Biotechnology
August 30, 2021
Cited by 167Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis